Nathan Eddy
Payouts by public healthcare companies have tripled since 2001, report says.
One of VBC's biggest issues is its reliance on complex financial models instead of direct provider enablement.
Hospitals and drugmakers are urging the president to exempt pharmaceuticals and medical goods from his new tariffs on Chinese imports.
AI automates the process of reading insurance card images and addresses potential claim denials in real time.
Success hinges on leveraging virtual health and digital tools to tailor solutions for diverse patient needs, says Yelena Bouaziz of Vizient.
There is a shift from treating a disease to preventing it, says PhRMA chief medical officer Dr. Mike Ybarra.
The expectation is AI will be widespread in revenue cycles within five years.
Fifteen percent of providers and 25% of payers report having an established AI strategy in 2024.
AI has emerged as a critical area of investment, with 57% of executives planning to invest this year.
The goal of Waltz Connect is to achieve transparency by unlocking competition among specialty pharmacies.